<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://ipharmag.com/article/sublingual-semaglutide-uk-compounding-novo</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31T12:05:21+00:00</news:publication_date>
      <news:title>Unlicensed Sublingual Semaglutide Offered to UK Doctors, Drawing a Novo Nordisk Warning</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/spatiotemporal-multiomics-liver-metastasis</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31T12:05:21+00:00</news:publication_date>
      <news:title>Scientists Map, Cell by Cell, How Liver Cancer Hides and Spreads to the Lungs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/resilience-lilly-750m-us-manufacturing</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31T12:05:21+00:00</news:publication_date>
      <news:title>Resilience and Lilly Add $750M to an Ohio Plant to Boost US Injectable-Drug Supply</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/mirecule-rio-biofarma-rna-delivery</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31T12:05:21+00:00</news:publication_date>
      <news:title>miRecule and Brazil&amp;rsquo;s EMS-RBBL Team Up to Deliver RNA Drugs Beyond the Liver</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/alnylam-earnings-plunge-ttr-competition</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31T12:05:21+00:00</news:publication_date>
      <news:title>Alnylam Shares Sink About 30% After a Surprise Guidance Cut</news:title>
    </news:news>
  </url>
</urlset>
